The percentage of participants who had weight reduction of 5% or more was 85%, 89%, and 91% with 5 mg, 10 mg, and 15 mg of tirzepatide, respectively, and 35% with placebo
In essence, GLP-1s are a toolnot a Swiss Army knife that can tackle every challengeand bistroMD can serve as another valuable instrument in your toolkit!
BMJ 353, i1585
Based on trial enrollment criteria, candidates typically had a BMI over 30 or a BMI of 27+ with weight-related health conditions like high cholesterol or high blood pressure
For semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), and liraglutide (Victoza, Saxenda), the Summaries of Product Characteristics confirm that the injection site does not significantly affect the pharmacokinetics of these medications
With rising costs and new supply challenges, many are rethinking their options